BSERavelcare LtdHighNeutral
Announced Sat, 30 May · 22:35 IST

Outcome of Board Meeting

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-13.3%1-day move
₹151.00
prior close
₹133.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.8-2.9-5.5-5.2-13.3-14.2-16.6-18.1-16.6-25.8-22.3
Up moveDown movePending
AI summary

Ravelcare Ltd's Board of Directors approved the audited financial results for the half year and financial year ended March 31, 2026. The statutory auditors (Ratan Chandak & Co. LLP) issued an unmodified (clean) opinion on the financial statements. Total assets and liabilities grew significantly to ₹3,762.62 Lakh from ₹1,162.44 Lakh in the previous year (over 3x growth). Share capital increased from ₹500.50 Lakh to ₹685.90 Lakh. Trade receivables nearly tripled from ₹247.66 Lakh to ₹710.56 Lakh. The Board also re-appointed M/s. Mahesh Dhabalia & Co. as Internal Auditors for FY 2026-27.

Likely market impact

The clean audit opinion is positive for shareholders as it indicates reliable financials without any concerns raised by auditors. The significant growth in assets suggests expansion, though the sharp rise in trade receivables warrants monitoring.